Treatment for hepatocellular carcinoma in the caudate lobe: a report of 13 cases

Wei Zhang; Yakun Wu; You Li; Jianping Gong; Hao Long

doi:10.18203/2349-2902.isj20173378

Authors

Wei Zhang Department of General Surgery, The People's Hospital of Jianyang City, Sichuan, China
Yakun Wu Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
You Li Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
Jianping Gong Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
Hao Long Department of Hepatobiliary Surgery, Dazu District People's Hospital, Chongqing, China

DOI:

https://doi.org/10.18203/2349-2902.isj20173378

Keywords:

Caudate lobe, Hepatic carcinoma, Surgical resection

Abstract

Background: To investigate therapies of hepatocellular carcinoma in the caudate lobe, surgical approach and method, surgical outcome of hepatic caudate lobotomy.

Methods: Clinical data of 13 patients with hepatocellular carcinoma in the caudate lobe who received surgical treatment in the Department of Hepatobiliary Surgery of the Second Affiliated Hospital of Chongqing Medical University from Jan 2010 to Jan 2014 was retrospectively analyzed.

Results: Two patients selected TACE therapy. However, tumor metastasis was observed on them in short term, and the therapeutic effect was poor after several times of treatment. Nine patients received surgical treatment. Surgical approaches included left approach, right approach and combined approaches from the left and right side; surgical method was part or complete caudate lobe resection combining with other liver segments. The operation time was 220.0-350.0 minutes, with the average value of 259.4 minutes. The vascular clamping time was 21.0-45.0 minutes, with the average value of 30.2 minutes. The bleeding volume was 400.0-1800.0 ml, with the average value of 844.4 ml. In all patients, there was no perioperative death and no postoperative liver failure happened, and 4 patients who suffered from interrelated complications were cured or got better by conservative treatments. All patients were followed up for 24 months. The recurrent rates of 1 and 2-year were 44.4%, 88.9% respectively, and the survival rates of 1 and 2 year were 66.7%, 44.4% respectively after surgical resection.

Conclusions: Resection is still the preferred therapeutic method for hepatocellular carcinoma in the caudate lobe. However, long-term outcomes of the therapy for hepatocellular carcinoma in the caudate lobe need further improvement.

Metrics

Metrics Loading ...

References

Nakaji S, Hirata N. Evaluation of the viability of hepatocellular carcinoma in the caudate lobe using contrast-enhanced endoscopic ultrasonography after transarterial chemoembolization. Endosc Ultrasound. 2016;5(6):390-2.

Abdalla EK, Vauthey JN, Couinaud C. The caudate lobe of the liver: implications of embryology and anatomy for surgery. Surg Oncol Clin N Am. 2002;11(4):835-48.

Dou JP, Yu J, Cheng ZG, Han ZY, Liu FY, Yu XL, et al. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma in the caudate lobe. Ultrasound Med Biol. 2016;42(8):1825-33.

Kim HC, Chung JW, Jae HJ, Yoon JH, Lee JH, Kim YJ, et al. Caudate lobe hepatocellular carcinoma treated with selective chemoembolization Radiol. 2010;257(1):278-87．

Tian G, Chen Q, Guo Y, Teng M, Li J. Surgical strategy for isolated caudate lobectomy: experience with 16 cases. HPB Surg. 2014;2014:983684.

Cheung TT, Yuen WK, Poon RT, Chan SC, Fan ST, Lo CM. Improved anterior hepatic transection for isolated hepatocellular carcinoma in the caudate. Hepatobiliary Pancreat Dis Int. 2014;13(2):219-22.

Yang JH, Gu J, Dong P, Chen L, Wu WG, Mu JS, Li ML, et al. Isolated complete caudate lobectomy for hepatic tumor of the anterior trans hepatic approach: surgical approaches and perioperative outcomes. World J Surg Oncol. 2013;11:197.

Viganò L, Costa G, Procopio F, Donadon M, Cimino M, Del Fabbro D, et al. Parenchyma-sparing liver surgery for large segment 1 tumors: ultrasound-guided lateral and superior approaches as safe alternatives to major hepatectomy. J Am Coll Surg. 2015;221(4):e65-73.

Goh BK, Chow PK, Teo JY, Wong JS, Chan CY, Cheow PC, et al. Number of nodules, child-pugh status, margin positivity, and microvascular invasion, but not tumor size, are prognostic factors of survival after liver resection for multifocal hepatocellular carcinoma. J Gastrointest Surg. 2014;18(8):1477-85.

Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, Komeda K, et al. Predictors of poor prognosis by recurrence patterns after curative hepatectomy for hepatocellular carcinoma in Child-Pugh classification. A. Hepatogastroenterol. 2015; 62(137):164-8.

Wong TC, Cheung TT, Chok KS, Chan AC, Dai WC, Chan SC, et al. Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus. HPB (Oxford). 2015;17(5):401-8.

Li C, Wen TF, Yan LN, Lu WS, Li B, Wang WT, et al. Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria. J Surg Res. 2016;4(209):8-16.

Zhou Y, Zhang X, Wu L, Xu D, Li B. Surgical outcomes of hepatocellular carcinoma originating from caudate lobe. ANZ J Surg. 2013;83(4):275-9.

Wahab MA, Fathy O, Elhanafy E, Atif E, Sultan AM, Salah T, et al. Caudate lobe resection for hepatocellular carcinoma. Hepatogastroenterol. 2011;58(112):1904-8.

Sakamoto Y, Nara S, Hata S, Yamamoto Y, Esaki M, Shimada K，et al．Prognosis of patients undergoing hepatectomy for solitary hepatocellular carcinoma originating in the caudate lobe．Surg. 2011;150(5):959-67．

Harada N, Shirabe K, Maeda T, Kayashima H, Ishida T, Maehara Y. Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child- Pughclass A patients. World J Surg. 2015;39(4):1044-51.